1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988 Dec 1;37(12):1595-607.
2. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome a new worldwide definition. The Lancet. 2005 Sep 24;366 (9491):
1059-62.
3. Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of
individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes care. 2004 Nov 1;27(11):2676-81.
4. Godwa V. Subclinical Thyroid dysfunction in subjects with metabolic syndrome. Journal of Biotechnology and
Biochemistry.2016;2(II):6.
5. Isomaa BO, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the
metabolic syndrome. Diabetes care. 2001 Apr 1;24(4):683-9.
6. Parapid B, Ostojic MC, Lalic NM, Micic DR, Damjanovic S, Bubanja D, et al. Risk factors clustering within the metabolic
syndrome: a pattern or by chance. HJC. 2014 Apr;55(2):92-100.
7. Strachan MW, Walker BR. Endocrine disease. Davidson Principles and Practice of Medicine ,London.Churchill Livingstone.
22nd ed.;2006:738-40.
8. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of internal medicine.
2000 Feb 28;160(4):526-34.
9. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines
for diagnosis and management. JAMA . 2004 Jan 14;291(2):228-38.
10. Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis.
Clinical cardiology. 2003 Dec 1;26(12):569-73.
11. Tseng FY, Lin WY, Lin CC, Lee LT, Li TC, Sung PK, et al. Subclinical hypothyroidism is associated with increased risk for all-
cause and cardiovascular mortality in adults. Journal of the American College of Cardiology. 2012 Aug 21;60(8):730-7.
12. Kota SK, Meher LK, Krishna SV, Modi KD. Hypothyroidism in metabolic syndrome. Indian Journal of Endocrinology &
Metabolism. 2012 Dec 1;16: 332-333
13. Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Serum free thyroxine concentration is associated with metabolic
syndrome in euthyroid subjects. Thyroid. 2014 Nov 1;24(11):1566-74.
14. Baral N, Lamsal M, Koner BC, Koirala S. Thyroid dysfunction in eastern Nepal. Southeast Asian Journal of Tropical Medicine
and Public Health. 2002 Sep 16;33(3):638-41.
15. Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocrine
Journal. 2007;54(1):71-6.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the
metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation.
2005 Oct 25;112(17):2735-52.
17. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Thyroid. 2002 May 1;12(5):421-5.
18. Ganidagli S, ErdoganM, Kosenti A, Kulaksizoglu M, Solmaz S, Sokmen, et al. Frequency of metabolic syndrome in hypothyroid
patients. Endocrine Abstracts 2009; 20: 97,
19. Haque R, Ferdousi S, Ferdousi SS, Rahman W, Uddin MN, Hoque MM. Metabolic Syndrome in Hypothyroid Patients. Bangladesh
Journal of Medical Biochemistry. 2015 Feb 26;7(2):57-61.
20. Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, et. al. A high normal TSH is associated with the metabolic
syndrome. Clinical Endocrinology. 2010 May 1;72(5):696-701.